Key Takeaways
- Steady growth, margin noise: Revenue grew 4.2% QoQ (4.3% CC) with all verticals growing sequentially for the second straight quarter, while reported EBITDA of 15.2% was weighed down by a one-time bankruptcy provision.
- A small client write-off distorts optics: A $1.75 mn provision for a Chapter 11 bankruptcy client and a 110 bps SG&A spike mask what management calls a normalized EBITDA of 16.3%, in line with its mid-teens commitment.
- The growth engine is broadening: Healthcare and BFSI led at 6.9% and 6.8% QoQ, while Data Engineering and Analytics surged 17.9%, showing cross-sell of service lines into existing accounts is gaining traction.
- Wage hikes land in Q2 with a known price tag: A $3 mn quarterly impact from July 1 salary increases will test management's ability to offset through pyramid optimization and on-site/offshore mix adjustments.
- What to watch next quarter: Whether the 4%+ growth pace holds against furloughs in TMT, the CrowdStrike outage's diversion of project dollars, and the margin impact of wage hikes.
Growth & Vertical Performance
- Broad-based sequential growth: All verticals grew QoQ for the second consecutive quarter, a pattern management has delivered in every quarter except Q3 of last year since the new team took over.
- Healthcare surges on new GTM: The vertical, started only in Q2 or Q3 of last year, grew 6.9% QoQ and was bolstered by the BridgeView Life Sciences acquisition, a consulting firm with deep Salesforce and Veeva expertise that adds a go-to-market engine for the pharmaceutical commercial segment.
- BFSI stays strong: The vertical grew 6.8% QoQ and has been relatively strong throughout, with positive momentum building over several quarters; management hopes the trend continues.
- TMT is the drag: Underperformance has been primarily in the TMT vertical, where furloughs of 1-2 weeks occurred in July and are a recurring seasonal feature; management declined to quantify the impact.
- Service lines cross-sell working: Service lines share of revenue rose to 53.2%, a 100 bps QoQ increase that management attributes to account planning driving penetration of Data Engineering (up 17.9% QoQ) and Advanced Engineering Services (up 9.3%) into existing accounts.
- South Africa masked by currency: Volume and constant-currency growth were good, but reported numbers were weakened by the rand declining roughly 10%.
Manish Tandon: "Irrespective of the environment, we continue to deliver growth quarter-on-quarter to our investors. And until now, since we have been there as this new management team, we have delivered growth every quarter, except for Q3 of last year."
Margin Walk & the Bankruptcy Distortion
- The headline miss has a simple explanation: EBITDA of 15.2% included a 110 bps SG&A increase driven almost entirely by a provision for doubtful debts from one client that filed Chapter 11 bankruptcy.
- Normalized performance was on track: Excluding that provision, normalized EBITDA was 16.3%, squarely in the mid-teens range management has committed to for the year.
- Gross margin slipped modestly: A 20 bps decline to 30.4% reflected 150 bps of operational cost pressure (travel, visa, licenses), partially offset by a 70 bps one-time R&D credit, 40 bps from higher utilization and volume, and a 20 bps exchange benefit.
- The bankrupt client is small and contained: The client billed roughly $300k per month; the $1.75 mn write-off covers pre-filing receivables, while post-bankruptcy work is protected by bankruptcy financing laws and expected to be paid, with Zensar positioned as a critical vendor.
- Wage hike lands next quarter: A $3 mn quarterly impact from July 1 salary increases will hit Q2; management plans to mitigate through pyramid optimization and on-site/offshore ratio adjustments but declined to quantify the net margin outcome, calling it a "3-billion-dollar question."
Manish Tandon: "The normalized EBITDA margin should be around 16.3%."
Order Book & Pipeline
- Flat order book seen as a positive: Q1 order book was flat year-on-year, which management views as a good sign given the strong Q2 results last year; the pipeline is described as "okay."
- Large-deal pipeline building: Management is still gunning for large deals, with a few in the pipeline and a hope to convert 1 or 2 of them; there has been a positive impact on the pipeline for large deals.
- Booking lag from last quarter: There is a lag in order booking from the roughly $180 mn booked last quarter, suggesting conversion timing remains a variable.
Headwinds & Risks
- CrowdStrike outage may divert spend: Management flagged that Q2 could see impact from the cybersecurity outage, as past incidents have diverted project dollars toward immediate security remediation, though no timeline was given for when or how this might materialize.
- Furloughs are a known TMT feature: Furloughs of 1-2 weeks occurred in July in the TMT vertical and are a recurring seasonal pattern; management declined to quantify the impact or comment on whether they are concentrated in the top customer.
- Experience Services dipped: The service line declined 3.1% QoQ after a strong previous quarter, a reminder that individual line performance can be lumpy.
- Macro environment stays volatile: Management expects markets to remain unchanged in FY25, citing macroeconomic uncertainty, geopolitical threats, and cybersecurity challenges as persistent factors.
- Tail accounts under-farmed: Some tail accounts have not been farmed effectively and represent an opportunity, while others have limited potential and are restricted to basic servicing.
Manish Tandon: "I hope it was not another Crowdstrike incident. But we were discussing bankruptcy. And see, first of all, this is a small client, about $300k per month of billing or so."
People & Operating Metrics
- Attrition improves further: LTM attrition fell to 10.6% from 10.9% last quarter, with employee happiness at 84% for two consecutive years and average variable payout at 100% for FY24.
- Net headcount rising: Net headcount increased for the second quarter in a row, signaling confidence in the demand pipeline.
- On-site mix stable: On-site revenue mix rose 1.4%, but effort mix increased only 0.4%; management expects it to stay within a small range with 0.5% fluctuations depending on project type.
- DSO at decade-best: Days sales outstanding are the best they have been in 10 years, and provisioning policies remain robust, supporting management's claim of solid revenue quality.
BridgeView Acquisition
- Strategic entry into Life Sciences consulting: BridgeView Life Sciences, a Pennsylvania-based technology and consulting firm, was acquired to create a go-to-market strategy for Healthcare and Life Sciences, with deep expertise in Salesforce and Veeva platforms focused on the pharmaceutical commercial segment.
- Talent and capability play: Management highlighted getting very good talent through the acquisition; the first town hall with the BridgeView team has already been held.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin | Mid-teen EBITDA margins for the full year | FY25 |
| Quarterly growth | Deliver growth quarter-on-quarter irrespective of environment | Ongoing, every quarter |
| Wage hike mitigation | Offset $3 mn quarterly impact through pyramid optimization and on-site/offshore adjustments | Q2 FY25 and beyond |
| Large deal conversion | Convert 1 or 2 large deals from current pipeline | No fixed date; "hopefully" |
| Industry growth parity | Aspire to be in line with industry growth this year, in leaders' quadrant next year | FY25, then FY26 |
| Guidance framework | Management has asked the Board to permit quarterly guidance | Board is deliberating; no timeline |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Revenue | $154.4 million, +4.2% QoQ reported, +4.3% QoQ constant currency |
| EBITDA margin | 15.2%, in line with mid-teens range; normalized EBITDA 16.3% excluding Chapter 11 provision |
| PAT margin | 12.3% |
| Gross margin | 30.4%, down 20 bps QoQ; operational costs of 150 bps offset by R&D credit, utilization, and forex |
| SG&A increase | +110 bps QoQ, primarily due to provision for doubtful debts from a client filing Chapter 11 |
| Order book | ₹15.4 crore |
| Cash and cash equivalents | $280.9 million, increased by $19.2 million QoQ |
| DSO | 72 days, improved by 1 day QoQ |
| Voluntary attrition (LTM) | 10.6%, improved from 10.9% last quarter |
| Utilization | 84%, improved 20 bps QoQ and 140 bps YoY |
| Headcount | +47 net addition vs Q4 FY24; gross addition of 855 employees |
| Service lines revenue share | 53.2%, up 100 bps QoQ |
| Wage hike impact (Q2 FY25 onward) | $3 million per quarter, roughly 180-200 bps margin impact |
| Chapter 11 client write-off | $1.75 million, 1.1% margin dilution; client billed ~$300k per month |